| Dr Kelly Ma, MD, MPH | |
|
1040 Nw 22nd Ave, Portland, OR 97210-3057 | |
| (503) 413-8498 | |
| Not Available |
| Full Name | Dr Kelly Ma |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 1040 Nw 22nd Ave, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346535267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD171281 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance-the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes. This breakthrough points to a new way to potentially treat or forestall type 2 diabetes, a rapidly growing global health problem.
Pavilion Financial Corporation, an employee-owned, diversified global investment services firm, today announced the acquisition of the business of Plan Sponsor Advisors, an investment and retirement benefit consulting firm specializing in defined contribution plans. The transaction is expected to close on or around June 20th.
More than 20 million men in the United States with a particular signature set of inherited characteristics and mutations in mitochondrial DNA (mtDNA) are at significantly increased risk for developing renal and prostate cancers, according to research at Emory University.
The National Institute of Environmental Health Sciences (NIEHS) has awarded Cornell insecticide toxicologist David Soderlund two grants, providing more than $2.5 million over five years, to study how insecticides affect human health.
› Verified 6 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance-the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes. This breakthrough points to a new way to potentially treat or forestall type 2 diabetes, a rapidly growing global health problem.
Pavilion Financial Corporation, an employee-owned, diversified global investment services firm, today announced the acquisition of the business of Plan Sponsor Advisors, an investment and retirement benefit consulting firm specializing in defined contribution plans. The transaction is expected to close on or around June 20th.
More than 20 million men in the United States with a particular signature set of inherited characteristics and mutations in mitochondrial DNA (mtDNA) are at significantly increased risk for developing renal and prostate cancers, according to research at Emory University.
The National Institute of Environmental Health Sciences (NIEHS) has awarded Cornell insecticide toxicologist David Soderlund two grants, providing more than $2.5 million over five years, to study how insecticides affect human health.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelly Ma, MD, MPH 85 E Concord St Fl 8, Dept Of Ophthalmology, Boston, MA 02118-2335 Ph: (617) 414-4020 | Dr Kelly Ma, MD, MPH 1040 Nw 22nd Ave, Portland, OR 97210-3057 Ph: (503) 413-8498 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance-the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes. This breakthrough points to a new way to potentially treat or forestall type 2 diabetes, a rapidly growing global health problem.
Pavilion Financial Corporation, an employee-owned, diversified global investment services firm, today announced the acquisition of the business of Plan Sponsor Advisors, an investment and retirement benefit consulting firm specializing in defined contribution plans. The transaction is expected to close on or around June 20th.
More than 20 million men in the United States with a particular signature set of inherited characteristics and mutations in mitochondrial DNA (mtDNA) are at significantly increased risk for developing renal and prostate cancers, according to research at Emory University.
The National Institute of Environmental Health Sciences (NIEHS) has awarded Cornell insecticide toxicologist David Soderlund two grants, providing more than $2.5 million over five years, to study how insecticides affect human health.
› Verified 6 days ago
Amy Ying Tong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1955 Nw Northrup St, Portland, OR 97209 Phone: 503-227-2020 | |
Sungjae Yang, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3375 Sw Terwilliger Bld, Casey Eye Institue, Portland, OR 97239 Phone: 503-494-5023 | |
Dr. Michael David Straiko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1040 Nw 22nd Ave., Suite 200, Portland, OR 97210 Phone: 503-413-8202 Fax: 503-413-6937 | |
Allison Rebecca Loh, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3375 Sw Terwilliger Blvd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
John Carl Morrison, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-418-0843 | |
Adam Marcus Hanif, Ophthalmology Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
Mr. John Jah-hyun Koo, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3600 N. Interstate Avenue, Department Of Opthalmology, Portland, OR 97227 Phone: 503-331-6330 Fax: 503-571-5877 |